MCP
TNYA icon

Mirador Capital Partners’s Tenaya Therapeutics TNYA Stock Holding History

Mirador Capital Partners’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$669K Buy
905,097
+18,180
+2% +$13.8K 0.08% 129
2026
Q1 		$614K Buy
886,917
+304,393
+52% +$225K 0.09% 128
2025
Q4 		$414K Buy
582,524
+559,024
+2,379% +$760K 0.06% 157
2025
Q3 		$38.1K Buy
23,500
+6,500
+38% +$6.55K 0.01% 214
2025
Q2 		$10.4K Buy
17,000
+2,000
+13% +$1.02K ﹤0.01% 200
2025
Q1 		$8.55K Buy
+15,000
New +$14.8K ﹤0.01% 197

Other funds holding TNYA

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
EL
EWA LLC Pittsbugh, Pennsylvania $548M AUM 35.14% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
VWM
Vermillion Wealth Management Rosemount, Minnesota $427M AUM 12.63% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Mirador Capital Partners's TNYA Position: Q2 2026 in Review

Mirador Capital Partners increased its Tenaya Therapeutics (TNYA) stake by 2% in Q2 2026, buying an estimated $13.8K and bringing the position to 905,097 shares worth $669K. The position accounts for 0.08% of the portfolio, ranked #129.

Mirador Capital Partners first reported a position in TNYA in Q1 2025 and has held it in 6 quarters since. 9 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Mirador Capital Partners held 905,097 shares of Tenaya Therapeutics worth $669K as of Q2 2026.
  • Mirador Capital Partners bought 18,180 Tenaya Therapeutics shares in Q2 2026, an estimated $13.8K.
  • Tenaya Therapeutics made up 0.08% of Mirador Capital Partners's portfolio in Q2 2026, its #129 holding.
  • Mirador Capital Partners first reported a position in Tenaya Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 9 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Mirador Capital Partners's 13F filing for Q2 2026, filed 7 Jul 2026.